Advertisement
Screener

Foghorn Therapeutics Inc. (FHTX) Long-term Debt, Gross

2.8 / 5 stars · 68/120 Roast Me

Foghorn Therapeutics Inc. Long-term Debt, Gross

Foghorn Therapeutics Inc. (FHTX) had Long-term Debt, Gross of $20.00 million as of 2020-12-31, per its 10-K filed 2021-03-18.

Discontinued › Notes › Debt › Debt Instruments

us-gaap:DebtInstrumentCarryingAmount · last filed 2021-03-18

  • 2020-12-31: Long-term Debt, Gross $20.00M.
  • 2020-09-30: Long-term Debt, Gross $14.50M.
  • 2019-12-31: Long-term Debt, Gross $15.00M.
Period endLong-term Debt, Gross
2020-12-31$20.00M
10-K · filed 2021-03-18
2020-09-30$14.50M
10-Q · filed 2020-12-04
2019-12-31$15.00M
10-K · filed 2021-03-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
Eledon Pharmaceuticals, Inc. (ELDN)United States$0.219B-3.23
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B
Nkarta, Inc. (NKTX)United States$0.205B-1.73
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
ORAMED PHARMACEUTICALS INC. (ORMP)$0.199B1.13
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Zentalis Pharmaceuticals, Inc. (ZNTL)United States$0.196B-2.48
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37